The first statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy
L. Bacharova, H. Estes, and L. Bang The first statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy J Electrocardiol 43 2010 197
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study
W.B. Kannel, T. Gordon, W.P. Castelli, and J.R. Margolis Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study Ann Intern Med 72 1970 813
Mannarino: Prognostic significance of isolated, non-specific left ventricular repolarization abnormalities in hypertension
G. Schillaci, M. Pirro, and L. Pasqualini Mannarino: prognostic significance of isolated, non-specific left ventricular repolarization abnormalities in hypertension J Hypertens 22 2004 407
Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men
J. Sundström, L. Lind, J. Arnlöv, B. Zethelius, B. Andrén, and H.O. Lithell Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men Circulation 103 2001 2346
Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients
LIFE Study Investigators
P.M. Okin, R.B. Devereux, M.S. Nieminen LIFE Study Investigators Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients Hypertension 44 2004 48
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events
P.M. Okin, R.B. Devereux, and S. Jern Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events JAMA 292 2004 2343
Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril
J. Mathew, P. Sleight, E. Lonn Heart Outcomes Prevention Evaluation (HOPE) Investigators Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril Circulation 104 2001 1615
Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension
Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
R.H. Fagard, J.A. Staessen, L. Thijs Systolic Hypertension in Europe (Syst-Eur) Trial Investigators Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension Hypertension 44 2004 459